Pseudomonas aeruginosa
Tobramycin has a narrow spectrum of activity and is active against Gram-positive "Staphylococcus aureus" and various Gram-negative bacteria. Clinically, tobramycin is frequently used to eliminate "Pseudomonas aeruginosa" in cystic fibrosis patients. The following represents MIC susceptibility data for a few strains of "Pseudomonas aeruginosa":